Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiomyopathy, Hypertrophic | 24 | 2024 | 1338 | 4.430 |
Why?
|
Benzylamines | 4 | 2024 | 251 | 0.960 |
Why?
|
Uracil | 4 | 2024 | 210 | 0.940 |
Why?
|
Ventricular Function, Left | 9 | 2024 | 3930 | 0.930 |
Why?
|
Ventricular Myosins | 1 | 2020 | 65 | 0.710 |
Why?
|
Stroke Volume | 6 | 2024 | 5595 | 0.660 |
Why?
|
Cardiomyopathies | 4 | 2024 | 2068 | 0.650 |
Why?
|
Echocardiography | 9 | 2024 | 5040 | 0.640 |
Why?
|
Fabry Disease | 1 | 2019 | 89 | 0.630 |
Why?
|
Heart Septum | 4 | 2024 | 303 | 0.580 |
Why?
|
Aortic Valve Insufficiency | 1 | 2022 | 575 | 0.570 |
Why?
|
Mediastinal Cyst | 1 | 2017 | 30 | 0.550 |
Why?
|
Diverticulum | 1 | 2017 | 137 | 0.500 |
Why?
|
Heart Ventricles | 3 | 2022 | 3833 | 0.430 |
Why?
|
Heart Neoplasms | 1 | 2017 | 374 | 0.420 |
Why?
|
Myocardial Contraction | 1 | 2017 | 1516 | 0.400 |
Why?
|
Pericardium | 1 | 2017 | 679 | 0.400 |
Why?
|
Exercise Tolerance | 1 | 2017 | 841 | 0.390 |
Why?
|
Contrast Media | 2 | 2024 | 5330 | 0.390 |
Why?
|
Ventricular Outflow Obstruction | 2 | 2023 | 262 | 0.340 |
Why?
|
Heart Valve Prosthesis | 1 | 2018 | 1464 | 0.330 |
Why?
|
Exercise Test | 1 | 2017 | 2185 | 0.320 |
Why?
|
Predictive Value of Tests | 6 | 2024 | 15401 | 0.310 |
Why?
|
Heart Atria | 1 | 2014 | 1363 | 0.300 |
Why?
|
Gadolinium | 2 | 2024 | 966 | 0.290 |
Why?
|
Genetic Association Studies | 1 | 2017 | 2744 | 0.280 |
Why?
|
Aortic Valve Stenosis | 2 | 2024 | 2022 | 0.280 |
Why?
|
Quality of Life | 3 | 2024 | 13463 | 0.250 |
Why?
|
Magnetic Resonance Imaging, Cine | 2 | 2024 | 1093 | 0.240 |
Why?
|
Cardiac Surgical Procedures | 2 | 2024 | 3682 | 0.240 |
Why?
|
Sequoia | 1 | 2023 | 6 | 0.220 |
Why?
|
Death, Sudden, Cardiac | 2 | 2024 | 1568 | 0.210 |
Why?
|
Ventricular Function, Right | 2 | 2024 | 629 | 0.200 |
Why?
|
Adipokines | 1 | 2024 | 308 | 0.190 |
Why?
|
Risk Assessment | 4 | 2024 | 24275 | 0.180 |
Why?
|
Proteomics | 2 | 2024 | 3906 | 0.180 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2024 | 346 | 0.170 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2024 | 855 | 0.160 |
Why?
|
Amyloid Neuropathies, Familial | 2 | 2024 | 187 | 0.160 |
Why?
|
Natriuretic Peptide, Brain | 3 | 2024 | 1735 | 0.160 |
Why?
|
Prognosis | 6 | 2024 | 29890 | 0.150 |
Why?
|
Technetium Tc 99m Pyrophosphate | 1 | 2017 | 54 | 0.140 |
Why?
|
Coronary Artery Disease | 1 | 2017 | 6544 | 0.140 |
Why?
|
Humans | 33 | 2024 | 765926 | 0.140 |
Why?
|
Heart Failure | 4 | 2024 | 11837 | 0.130 |
Why?
|
Coronary Vessel Anomalies | 1 | 2019 | 308 | 0.130 |
Why?
|
Diagnosis, Differential | 3 | 2024 | 12973 | 0.120 |
Why?
|
Nonlinear Dynamics | 1 | 2017 | 490 | 0.120 |
Why?
|
Treatment Outcome | 8 | 2024 | 65194 | 0.120 |
Why?
|
Disopyramide | 2 | 2024 | 16 | 0.120 |
Why?
|
Middle Aged | 15 | 2024 | 223016 | 0.110 |
Why?
|
Ventricular Remodeling | 1 | 2022 | 1276 | 0.110 |
Why?
|
Echocardiography, Doppler | 1 | 2017 | 899 | 0.110 |
Why?
|
Male | 18 | 2024 | 363815 | 0.110 |
Why?
|
Cause of Death | 1 | 2024 | 3715 | 0.100 |
Why?
|
Female | 18 | 2024 | 396141 | 0.100 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2017 | 1143 | 0.100 |
Why?
|
Recovery of Function | 2 | 2024 | 2963 | 0.100 |
Why?
|
Diastole | 1 | 2014 | 785 | 0.100 |
Why?
|
Peptide Fragments | 2 | 2024 | 5126 | 0.100 |
Why?
|
Sex Characteristics | 1 | 2022 | 2645 | 0.090 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3430 | 0.090 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2022 | 2136 | 0.090 |
Why?
|
Fibrosis | 1 | 2018 | 2073 | 0.090 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2024 | 772 | 0.080 |
Why?
|
Aged | 13 | 2024 | 171163 | 0.080 |
Why?
|
Prospective Studies | 5 | 2024 | 54807 | 0.080 |
Why?
|
Heart Diseases | 1 | 2022 | 2818 | 0.080 |
Why?
|
Aortic Valve | 1 | 2018 | 1964 | 0.080 |
Why?
|
Myocardium | 1 | 2021 | 4764 | 0.070 |
Why?
|
Radiopharmaceuticals | 1 | 2017 | 2701 | 0.070 |
Why?
|
Time Factors | 4 | 2024 | 40097 | 0.070 |
Why?
|
Coronary Angiography | 1 | 2019 | 4498 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6503 | 0.070 |
Why?
|
Risk Factors | 5 | 2024 | 74850 | 0.070 |
Why?
|
Atrial Fibrillation | 1 | 2024 | 5186 | 0.060 |
Why?
|
Adult | 9 | 2024 | 223088 | 0.060 |
Why?
|
Heart Defects, Congenital | 1 | 2022 | 4712 | 0.060 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12059 | 0.060 |
Why?
|
Electrocardiography | 1 | 2017 | 6409 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 12529 | 0.050 |
Why?
|
Genotype | 1 | 2017 | 13026 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2024 | 10727 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 2 | 2021 | 36547 | 0.050 |
Why?
|
Retrospective Studies | 4 | 2024 | 81537 | 0.050 |
Why?
|
Calcium Channel Blockers | 1 | 2024 | 685 | 0.050 |
Why?
|
Glycine | 1 | 2024 | 671 | 0.050 |
Why?
|
Oligonucleotides | 1 | 2023 | 561 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2024 | 1102 | 0.040 |
Why?
|
Japan | 1 | 2024 | 1411 | 0.040 |
Why?
|
Withholding Treatment | 1 | 2024 | 619 | 0.040 |
Why?
|
Standard of Care | 1 | 2024 | 568 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2024 | 12417 | 0.040 |
Why?
|
Blood Proteins | 1 | 2024 | 1186 | 0.040 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2024 | 1238 | 0.040 |
Why?
|
Phenotype | 1 | 2017 | 16714 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2024 | 39228 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2024 | 20690 | 0.040 |
Why?
|
Cross-Over Studies | 1 | 2023 | 2108 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2024 | 22228 | 0.030 |
Why?
|
Decision Support Techniques | 1 | 2024 | 2004 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2024 | 2782 | 0.030 |
Why?
|
Pyrimidines | 1 | 2024 | 3049 | 0.020 |
Why?
|
Cohort Studies | 2 | 2024 | 41680 | 0.020 |
Why?
|
Health Status | 1 | 2024 | 4085 | 0.020 |
Why?
|
Signal Transduction | 2 | 2024 | 23597 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2024 | 3310 | 0.020 |
Why?
|
Animals | 1 | 2020 | 168735 | 0.020 |
Why?
|
Patient Care Team | 1 | 2018 | 2515 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2024 | 15878 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2019 | 4037 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2018 | 3615 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2017 | 20133 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2017 | 59496 | 0.010 |
Why?
|
Adolescent | 1 | 2019 | 88811 | 0.010 |
Why?
|
Concepts
(115)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(25)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_